Work is ongoing to identify the precise molecular mechanisms underlying the 3′UTR-induced suppression of ECE-1 expression, but our findings suggest this may be a novel mechanism responsible for ECE-1 over-expression in cancer cells and may therefore represent a novel therapeutic target. The gene discussed is ECE1; the disease is cancer.